Business Description
Microbot Medical Inc
NAICS : 339112
SIC : 5047
ISIN : US59503A2042
Total Employee Number:
22Description
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 76.9 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.05 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 12.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 44.1 | |||||
3-Year EPS without NRI Growth Rate | 46 | |||||
3-Year FCF Growth Rate | 43.7 | |||||
3-Year Book Growth Rate | 7.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.92 | |||||
9-Day RSI | 37.81 | |||||
14-Day RSI | 38.99 | |||||
3-1 Month Momentum % | 1.16 | |||||
6-1 Month Momentum % | -18.6 | |||||
12-1 Month Momentum % | -43.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.56 | |||||
Quick Ratio | 17.82 | |||||
Cash Ratio | 17.33 | |||||
Days Inventory | 708.55 | |||||
Days Sales Outstanding | 148.22 | |||||
Days Payable | 257.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -104.2 | |||||
Shareholder Yield % | -52.31 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -185.26 | |||||
Operating Margin % | -5348.84 | |||||
Net Margin % | -4722.25 | |||||
EBITDA Margin % | -5335.26 | |||||
FCF Margin % | -5181.79 | |||||
OCF Margin % | -5098.55 | |||||
ROE % | -24.82 | |||||
ROA % | -23.48 | |||||
ROIC % | -869.04 | |||||
3-Year ROIIC % | -92.04 | |||||
ROC (Joel Greenblatt) % | -1418.38 | |||||
ROCE % | -27.91 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 14.25 | |||||
PS Ratio | 258.33 | |||||
PB Ratio | 1.5 | |||||
Price-to-Tangible-Book | 1.5 | |||||
EV-to-EBIT | -2.03 | |||||
EV-to-EBITDA | -2.04 | |||||
EV-to-Revenue | 108.71 | |||||
EV-to-Forward-Revenue | 23.88 | |||||
EV-to-FCF | -2.1 | |||||
| Price-to-Net-Current-Asset-Value | 1.53 | |||||
| Price-to-Net-Cash | 1.65 | |||||
Earnings Yield (Greenblatt) % | -49.26 | |||||
FCF Yield % | -17.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MBOT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microbot Medical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.346 | ||
| EPS (TTM) ($) | -0.24 | ||
| Beta | 0.4405 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.27 | ||
| Volatility % | 78.36 | ||
| 14-Day RSI | 38.99 | ||
| 14-Day ATR ($) | 0.099144 | ||
| 20-Day SMA ($) | 1.713 | ||
| 12-1 Month Momentum % | -43.37 | ||
| 52-Week Range ($) | 1.44 - 4.67 | ||
| Shares Outstanding (Mil) | 67.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Microbot Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Microbot Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 84 days | ||
| General meeting for 2026 | 2026-08-12 | 1.68 (-11.11%) | ||
| Second quarter earnings results for 2026 | 2026-08-11 | 1.94 (+2.93%) | ||
| Analysts and Investors Conference Call | 2026-05-18 15:00 | 1.85 (-0.54%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 2.19 (+2.34%) | ||
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-15 10:15 | 2.43 (+0.83%) | ||
| Annual report for 2025 | 2026-03-26 | 2.53 (-0.39%) | ||
| 38th Annual Roth Conference | 2026-03-23 16:00 | 2.54 (-3.05%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 2.09 (+0.48%) | ||
| Second quarter earnings results for 2025 | 2025-08-12 | 2.89 (-6.47%) |
Show
Entries
Microbot Medical Inc Frequently Asked Questions
What is Microbot Medical Inc(MBOT)'s stock price today?
The current price of MBOT is $1.55. The 52 week high of MBOT is $4.67 and 52 week low is $1.44.
When is next earnings date of Microbot Medical Inc(MBOT)?
The next earnings date of Microbot Medical Inc(MBOT) is 2026-11-12 Est..
Does Microbot Medical Inc(MBOT) pay dividends? If so, how much?
Microbot Medical Inc(MBOT) does not pay dividend.
Guru Commentaries on NAS:MBOT
No articles.
Press Release
Articles on Microbot Medical Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers